Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Leukemia

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    March 2020
  1. FLOREN M, Restrepo Cruz S, Termini CM, Marjon KD, et al
    Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and beta1 integrin activation.
    Oncogene. 2020 Mar 19. pii: 10.1038/s41388-020-1261.
    PubMed     Abstract available


  2. SHIBATA N, Ohoka N, Tsuji G, Demizu Y, et al
    Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells.
    Oncogene. 2020 Mar 12. pii: 10.1038/s41388-020-1253.
    PubMed     Abstract available


  3. LI Z, Philip M, Ferrell PB
    Alterations of T-cell-mediated immunity in acute myeloid leukemia.
    Oncogene. 2020 Mar 3. pii: 10.1038/s41388-020-1239.
    PubMed     Abstract available


    February 2020
  4. WANG Y, Liu Y, Bailey C, Zhang H, et al
    Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1alpha with echinomycin.
    Oncogene. 2020 Feb 15. pii: 10.1038/s41388-020-1201.
    PubMed     Abstract available


    November 2019
  5. BARAK AF, Lewinsky H, Perpinial M, Huber V, et al
    Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner.
    Oncogene. 2019 Nov 26. pii: 10.1038/s41388-019-1121.
    PubMed     Abstract available


  6. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Correction: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Nov 7. pii: 10.1038/s41388-019-1089.
    PubMed     Abstract available


    October 2019
  7. KOUZI F, Zibara K, Bourgeais J, Picou F, et al
    Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Oncogene. 2019 Oct 24. pii: 10.1038/s41388-019-1069.
    PubMed     Abstract available


  8. PINTO I, Duque M, Goncalves J, Akkapeddi P, et al
    NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling.
    Oncogene. 2019 Oct 4. pii: 10.1038/s41388-019-1042.
    PubMed     Abstract available


    September 2019
  9. JI D, Zhang P, Ma W, Fei Y, et al
    Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1.
    Oncogene. 2019 Sep 5. pii: 10.1038/s41388-019-0998.
    PubMed     Abstract available


    August 2019
  10. SECKER KA, Keppeler H, Duerr-Stoerzer S, Schmid H, et al
    Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0937.
    PubMed     Abstract available


  11. BUFFIERE A, Uzan B, Aucagne R, Hermetet F, et al
    T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0921.
    PubMed     Abstract available


    July 2019
  12. HOUNJET J, Habets R, Schaaf MB, Hendrickx TC, et al
    The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to gamma-secretase inhibition.
    Oncogene. 2019;38:5457-5468.
    PubMed     Abstract available


    June 2019
  13. KRESINSKY A, Schnoder TM, Jacobsen ID, Rauner M, et al
    Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.
    Oncogene. 2019;38:4773-4787.
    PubMed     Abstract available


    April 2019
  14. NICOLAE CM, O'Connor MJ, Schleicher EM, Song C, et al
    PARI (PARPBP) suppresses replication stress-induced myeloid differentiation in leukemia cells.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0810.
    PubMed     Abstract available


    March 2019
  15. HIRANO D, Hayakawa F, Yasuda T, Tange N, et al
    Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.
    Oncogene. 2019;38:2263-2274.
    PubMed     Abstract available


    February 2019
  16. AGUILERA-MONTILLA N, Bailon E, Uceda-Castro R, Ugarte-Berzal E, et al
    MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
    Oncogene. 2019 Feb 13. pii: 10.1038/s41388-019-0744.
    PubMed     Abstract available


  17. VAZQUEZ-DOMINGUEZ I, Gonzalez-Sanchez L, Lopez-Nieva P, Fernandez-Navarro P, et al
    Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0746.
    PubMed     Abstract available


    January 2019
  18. SOMERS K, Wen VW, Middlemiss SMC, Osborne B, et al
    A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
    Oncogene. 2019 Jan 22. pii: 10.1038/s41388-018-0666.
    PubMed     Abstract available


  19. KARVONEN H, Perttila R, Niininen W, Hautanen V, et al
    Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Oncogene. 2019 Jan 10. pii: 10.1038/s41388-018-0670.
    PubMed     Abstract available


  20. LAU BW, Huh K, Madero-Marroquin R, De Marchi F, et al
    Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.
    Oncogene. 2019;38:687-698.
    PubMed     Abstract available


  21. CHEN-WICHMANN L, Shvartsman M, Preiss C, Hockings C, et al
    Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
    Oncogene. 2019;38:261-272.
    PubMed     Abstract available


    December 2018
  22. SHIRAI YT, Mizutani A, Nishijima S, Horie M, et al
    CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.
    Oncogene. 2018 Dec 10. pii: 10.1038/s41388-018-0603.
    PubMed     Abstract available


  23. GIANNI M, Terao M, Kurosaki M, Paroni G, et al
    S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0599.
    PubMed     Abstract available


  24. TRAXEL S, Schadt L, Eyer T, Mordasini V, et al
    Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.
    Oncogene. 2018 Dec 7. pii: 10.1038/s41388-018-0594.
    PubMed     Abstract available


    November 2018
  25. URTISHAK KA, Wang LS, Culjkovic-Kraljacic B, Davenport JW, et al
    Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Oncogene. 2018 Nov 26. pii: 10.1038/s41388-018-0567.
    PubMed     Abstract available


    October 2018
  26. MCLEAN K, Tan L, Bolland DE, Coffman LG, et al
    Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0523.
    PubMed     Abstract available


  27. CHONG PSY, Zhou J, Chooi JY, Chan ZL, et al
    Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia.
    Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0526.
    PubMed     Abstract available


    September 2018
  28. CHIANG YJ, Liao WT, Ho KC, Wang SH, et al
    CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
    Oncogene. 2018 Sep 28. pii: 10.1038/s41388-018-0507.
    PubMed     Abstract available


  29. CHOW M, Gao L, MacManiman JD, Bicocca VT, et al
    Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.
    Oncogene. 2018;37:5221-5232.
    PubMed     Abstract available


  30. STAMM H, Klingler F, Grossjohann EM, Muschhammer J, et al
    Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option.
    Oncogene. 2018;37:5269-5280.
    PubMed     Abstract available


    August 2018
  31. SWAROOP A, Oyer JA, Will CM, Huang X, et al
    An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0474.
    PubMed     Abstract available


  32. GOROSHCHUK O, Kolosenko I, Vidarsdottir L, Azimi A, et al
    Polo-like kinases and acute leukemia.
    Oncogene. 2018 Aug 13. pii: 10.1038/s41388-018-0443.
    PubMed     Abstract available


    July 2018
  33. FERRANDINO F, Bernardini G, Tsaouli G, Grazioli P, et al
    Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
    Oncogene. 2018 Jul 23. pii: 10.1038/s41388-018-0401.
    PubMed     Abstract available


  34. NICOLAE CM, O'Connor MJ, Constantin D, Moldovan GL, et al
    NFkappaB regulates p21 expression and controls DNA damage-induced leukemic differentiation.
    Oncogene. 2018;37:3647-3656.
    PubMed     Abstract available


    June 2018
  35. ZHANG Y, Zhou X, Li Y, Xu Y, et al
    Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia.
    Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0333.
    PubMed     Abstract available


    May 2018
  36. GERLACH D, Tontsch-Grunt U, Baum A, Popow J, et al
    The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML.
    Oncogene. 2018;37:2687-2701.
    PubMed     Abstract available


  37. LIN J, Ma JC, Yang J, Yin JY, et al
    Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression.
    Oncogene. 2018;37:2432-2443.
    PubMed     Abstract available


    April 2018
  38. PINAZZA M, Ghisi M, Minuzzo S, Agnusdei V, et al
    Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.
    Oncogene. 2018 Apr 12. pii: 10.1038/s41388-018-0234.
    PubMed     Abstract available


    March 2018
  39. ZHU Y, Lu L, Qiao C, Shan Y, et al
    Targeting PFKFB3 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitor.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0157.
    PubMed     Abstract available


  40. PATRUSSI L, Capitani N, Cattaneo F, Manganaro N, et al
    p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from beta-arrestin at early endosomes.
    Oncogene. 2018;37:1534-1550.
    PubMed     Abstract available


    February 2018
  41. ABDUL-AZIZ AM, Shafat MS, Sun Y, Marlein CR, et al
    HIF1alpha drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
    Oncogene. 2018 Feb 28. pii: 10.1038/s41388-018-0151.
    PubMed     Abstract available


  42. DI COSTANZO A, Del Gaudio N, Conte L, Dell'Aversana C, et al
    The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.
    Oncogene. 2018 Feb 22. pii: 10.1038/s41388-018-0143.
    PubMed     Abstract available


  43. WANG H, Bei L, Shah CA, Huang W, et al
    The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
    Oncogene. 2018 Feb 20. pii: 10.1038/s41388-018-0131.
    PubMed     Abstract available


    January 2018
  44. LARMONIE NSD, Arentsen-Peters TCJM, Obulkasim A, Valerio D, et al
    MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Oncogene. 2018;37:107-115.
    PubMed     Abstract available


    October 2017
  45. HEYDT Q, Larrue C, Saland E, Bertoli S, et al
    Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  46. ABBACI A, Talbot H, Saada S, Gachard N, et al
    Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    September 2017
  47. SERIO J, Ropa J, Chen W, Mysliwski M, et al
    The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  48. YOUN H, Lee HK, Sohn HR, Park UH, et al
    RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    August 2017
  49. D'ABUNDO L, Callegari E, Bresin A, Chillemi A, et al
    Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    July 2017
  50. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    June 2017
  51. ZIMMERMANNOVA O, Doktorova E, Stuchly J, Kanderova V, et al
    An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  52. KANG SM, Rosales JL, Meier-Stephenson V, Kim S, et al
    Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  53. GUO A, Lu P, Lee J, Zhen C, et al
    HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment.
    Oncogene. 2017;36:3441-3449.
    PubMed     Abstract available


  54. TSURUTA-KISHINO T, Koya J, Kataoka K, Narukawa K, et al
    Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Oncogene. 2017;36:3300-3311.
    PubMed     Abstract available


    April 2017
  55. BURGESS M, Mapp S, Mazzieri R, Cheung C, et al
    Increased FcgammaRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.
    Oncogene. 2017;36:2366-2376.
    PubMed     Abstract available


  56. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  57. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Abstract available


    March 2017
  58. TSAI CT, So CW
    Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Oncogene. 2017;36:1753-1759.
    PubMed     Abstract available


  59. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: